1
TITLE: A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
AUTHORS: Green, MD; Koelbl, H; Baselga, J; Galid, A; Guillem, V; Gascon, P; Siena, S; Lalisang, RI; Samonigg, H; Clemens, MR; Zani, V; Liang, BC; Renwick, J; Piccart, MJ; Yang, BB; Bashir, S; Hill, LR; Breddy, J; Foote, MA; Ackland, SP; Andreesen, R; Bashford, J; Cascinu, S; Cocconi, G; Cocquyt, V; Coleman, RE; Dunlop, D; Grothey, A; Holmes, FA; Koczwara, B; Lind, MJ; Lluch, A; Marques, F; Miles, D; Richardson, GE; Santoro, A; Schaafsma, MR; ...More
PUBLISHED: 2003, SOURCE: Annals of Oncology, VOLUME: 14, ISSUE: 1
INDEXED IN: Scopus CrossRef